From Our Partners
Friday, June 24, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

U.S. Donates One Million Doses of Swine Fever Vaccine to Guatemala

by Global Biodefense Staff
March 30, 2013

The United States Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) transferred one million doses of Classical Swine Fever (CSF) vaccine to Guatemala’s Ministry of Agriculture and Food Safety this month. 

“APHIS recognizes the prevalence of CSF in Guatemala and responded immediately to their request for assistance to help control their latest outbreak,” said Dr. John R. Clifford, USDA’s Chief Veterinary Officer.  “We sent a team of subject matter experts to assess the situation and concluded that the use of much-needed vaccine would help in containing the spread of the disease.” 

On March 19, APHIS donated the vaccines based on a request for assistance from the Guatemalan Chief Veterinary Officer, Dr. Humberto Maldonado, to help Guatemala control the spread of CSF there.

This assistance will help control and limit spread of CSF in Guatemala and neighboring countries. Among these countries are Mexico, currently working to control and eradicate the disease, and the United States, which has been free of CSF for over 30 years. Thus, this assistance extends beyond Guatemala and contributes to safeguarding animal health throughout Central and North America. 

As Guatemala implements their vaccination campaign, APHIS will take the opportunity to study the impact of the vaccine on surveillance and diagnostics when implemented in a field environment. Subject Matter Experts from the Centers for Epidemiology and Animal Health, the Plum Island Animal Disease Center, and the Guatemalan Ministry of Agriculture are currently working together to design the study.

The one million vaccines were part of the National Veterinary Stockpile (NVS). Established in 2004 by a Presidential directive, the NVS helps protect the Nation’s food supply by quickly providing necessary resources during an animal disease outbreak. This allows animal health officials to deliver a rapid and effective disease response. With NVS support, officials can set up immediate measures to contain and eradicate the disease, minimizing the animal losses, market disruptions, and other economic damages that result from an outbreak. 

Source: APHIS

From Our Partners
Tags: Agro-DefenseVaccines

Related Posts

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
masked medical laboratory technician waits on samples to process in a biocontainment lab
Biosecurity

Design Phase Kicks Off for New $750M Wadsworth Public Health Laboratory

May 1, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC